Published in Clin Pharmacol Ther on September 01, 2001
Mechanisms of acetaminophen-induced liver necrosis. Handb Exp Pharmacol (2010) 2.54
Current concepts and controversies in the treatment of alcoholic hepatitis. World J Gastroenterol (2006) 1.17
The role of chemokines in acute liver injury. Front Physiol (2012) 1.09
The potential of cytokines as safety biomarkers for drug-induced liver injury. Eur J Clin Pharmacol (2010) 0.89
Serum interleukin-8 in children with biliary atresia: relationship with disease stage and biochemical parameters. Pediatr Surg Int (2004) 0.85
A retrospective evaluation of shortened-duration oral N-acetylcysteine for the treatment of acetaminophen poisoning. J Med Toxicol (2009) 0.84
Investigation of the direct hepatic effects of intramuscular interleukin-8 injection in an experimental rabbit model. Med Sci Monit Basic Res (2013) 0.75
Role of the Inflammasome in Acetaminophen-induced Liver Injury and Acute Liver Failure. J Hepatol (2016) 0.75
Xylem embolism in response to freeze-thaw cycles and water stress in ring-porous, diffuse-porous, and conifer species. Plant Physiol (1992) 2.79
Extracorporeal membrane oxygenation and early-onset group B streptococcal sepsis. Pediatrics (1992) 2.67
Ontogeny of dextromethorphan O- and N-demethylation in the first year of life. Clin Pharmacol Ther (2007) 2.17
Evidence of gentamicin nephrotoxicity in patients with renal allografts. Br Med J (1975) 2.05
Vascular and hepatocellular peroxynitrite formation during acetaminophen toxicity: role of mitochondrial oxidant stress. Toxicol Sci (2001) 2.00
Pharmacokinetic studies in paediatric patients. Clinical and ethical considerations. Clin Pharmacokinet (1992) 1.94
Pediatric acetaminophen overdose: risk factors associated with hepatocellular injury. Arch Pediatr Adolesc Med (2000) 1.80
Glucuronidation in humans. Pharmacogenetic and developmental aspects. Clin Pharmacokinet (1999) 1.79
TAC use and absorption of cocaine in a pediatric emergency department. Ann Emerg Med (1990) 1.75
Variation in therapy and outcome for pediatric head trauma patients. Crit Care Med (2001) 1.69
Pretreatment of mice with macrophage inactivators decreases acetaminophen hepatotoxicity and the formation of reactive oxygen and nitrogen species. Hepatology (1999) 1.68
Population pharmacokinetics of fluconazole in young infants. Antimicrob Agents Chemother (2008) 1.68
Cytochrome P450 3A: ontogeny and drug disposition. Clin Pharmacokinet (1999) 1.67
Selective protein covalent binding and target organ toxicity. Toxicol Appl Pharmacol (1997) 1.66
Syndrome of inappropriate antidiuretic hormone secretion in children following spinal fusion. Crit Care Med (1999) 1.60
Immunohistochemical localization and quantification of the 3-(cystein-S-yl)-acetaminophen protein adduct in acetaminophen hepatotoxicity. Am J Pathol (1991) 1.57
Optimized conditions for the growth of human epidermal cells in culture. J Invest Dermatol (1980) 1.57
Acute hepatic failure associated with the use of sodium valproate. N Engl J Med (1979) 1.55
Bradycardia during anesthesia in infants. An epidemiologic study. Anesthesiology (1994) 1.53
Acetaminophen-associated hepatic injury: evaluation of acetaminophen protein adducts in children and adolescents with acetaminophen overdose. Clin Pharmacol Ther (2008) 1.48
Clinical pharmacology: a discipline called to action for maternal and child health. Clin Pharmacol Ther (2007) 1.46
Video-EEG monitoring in newborns with hypoxic-ischemic encephalopathy treated with hypothermia. Neurology (2011) 1.45
Lomotil overdose. Pediatrics (1991) 1.40
BLOOD-BORNE PYOGENIC INFECTIONS OF BONES AND JOINTS. Ann Surg (1940) 1.39
Application of pharmacokinetics in the diagnosis of chemical abuse in Münchausen syndrome by proxy. Clin Pediatr (Phila) (1988) 1.38
Optimization of cytochrome P4502D6 (CYP2D6) phenotype assignment using a genotyping algorithm based on allele frequency data. Pharmacogenetics (1999) 1.36
Acetaminophen overdose with therapeutic intent. J Pediatr (1998) 1.29
Immunochemical quantitation of 3-(cystein-S-yl)acetaminophen adducts in serum and liver proteins of acetaminophen-treated mice. J Pharmacol Exp Ther (1989) 1.28
Biochemical characterization and deletion analysis of recombinant human protein phosphatase 2C alpha. Biochem J (1996) 1.27
Immediate action needed to improve labeling of prescription drugs for pediatric patients. Ann Pharmacother (1997) 1.25
Developmental pharmacodynamics of cyclosporine. Clin Pharmacol Ther (1999) 1.22
Cefotaxime and desacetylcefotaxime pharmacokinetics in infants and children with meningitis. Antimicrob Agents Chemother (1985) 1.20
Dosing implications of altered gentamicin disposition in patients with cystic fibrosis. J Pediatr (1982) 1.19
Volume-outcome relationships in pediatric intensive care units. Pediatrics (2000) 1.19
The accumulation of whole body skeletal mass in third- and fourth-grade children: effects of age, gender, ethnicity, and body composition. Bone (1997) 1.19
Injuries associated with downhill sledding. Pediatr Emerg Care (1987) 1.18
Considerations in the rational design and conduct of phase I/II pediatric clinical trials: avoiding the problems and pitfalls. Clin Pharmacol Ther (2007) 1.18
The spontaneous and enzymatic reaction of N-acetyl-p-benzoquinonimine with glutathione: a stopped-flow kinetic study. Arch Biochem Biophys (1988) 1.17
Treatment of neonatal hypertension with enalaprilat. J Pediatr (1990) 1.17
Acetaminophen-induced hepatotoxicity in mice lacking inducible nitric oxide synthase activity. Nitric Oxide (2001) 1.16
A sensitive immunochemical assay for acetaminophen-protein adducts. J Pharmacol Exp Ther (1987) 1.13
Combined phenotypic assessment of CYP1A2, CYP2C19, CYP2D6, CYP3A, N-acetyltransferase-2, and xanthine oxidase with the "Cooperstown cocktail". Clin Pharmacol Ther (2000) 1.12
Acetaminophen-induced hepatic glycogen depletion and hyperglycemia in mice. Biochem Pharmacol (1983) 1.12
Efficacy, disposition and pharmacodynamics of aspirin, acetaminophen and choline salicylate in young febrile children. Ther Drug Monit (1982) 1.12
Pharmacogenetics in pediatrics. Implications for practice. Pediatr Clin North Am (1997) 1.12
Clostridium difficile in patients undergoing primary hip and knee replacement. J Bone Joint Surg Br (2010) 1.12
Predicting outcome in children with severe acute respiratory failure treated with high-frequency ventilation. Crit Care Med (1996) 1.12
Single-dose, placebo-controlled comparative study of ibuprofen and acetaminophen antipyresis in children. J Pediatr (1991) 1.10
Acetaminophen-induced hepatotoxicity. Life Sci (1981) 1.09
Immunochemical detection of oxidized proteins. Chem Res Toxicol (1993) 1.09
Interactions of inflammatory pain and morphine in infant rats: long-term behavioral effects. Physiol Behav (2001) 1.08
Mortality within the first 2 years in infants exposed to cocaine, opiate, or cannabinoid during gestation. Pediatrics (1997) 1.08
Antinuclear antibodies as potential markers of lung cancer. Clin Cancer Res (1999) 1.08
Stereoselective formation of bromobenzene glutathione conjugates. Chem Biol Interact (1982) 1.08
Nosocomial infections during extracorporeal membrane oxygenation. Intensive Care Med (2001) 1.06
Single-dose pharmacokinetics of ibuprofen and acetaminophen in febrile children. J Clin Pharmacol (1992) 1.06
Treatment of pain with gabapentin in a neonate. Pediatrics (2001) 1.05
Covalent binding of xenobiotics to specific proteins in the liver. Drug Metab Rev (1997) 1.03
Generation of reactive metabolites of N-hydroxy-phenacetin by glucoronidation and sulfation. Biochem Pharmacol (1977) 1.02
The neurotoxicity of cyclotrimethylenetrinitramine (RDX) in a child: a clinical and pharmacokinetic evaluation. J Toxicol Clin Toxicol (1986) 1.01
Cocaine: clinical pharmacology and toxicology. J Pediatr (1989) 1.01
Quantitation of three-month intraindividual variability and influence of sex and menstrual cycle phase on CYP1A2, N-acetyltransferase-2, and xanthine oxidase activity determined with caffeine phenotyping. Clin Pharmacol Ther (1998) 0.99
Potent inhibition of cytochrome P-450 2D6-mediated dextromethorphan O-demethylation by terbinafine. Drug Metab Dispos (1999) 0.99
Evolution of obesity in a low birth weight cohort. J Perinatol (2011) 0.99
Loxoscelism and necrotic arachnidism. J Toxicol Clin Toxicol (1984) 0.98
Measurement of acetaminophen-protein adducts in children and adolescents with acetaminophen overdoses. . J Clin Pharmacol (2001) 0.98
Immunoblot analysis of protein containing 3-(cystein-S-yl)acetaminophen adducts in serum and subcellular liver fractions from acetaminophen-treated mice. Toxicol Appl Pharmacol (1990) 0.98
Immunochemical quantitation of 3-(cystein-S-yl)acetaminophen protein adducts in subcellular liver fractions following a hepatotoxic dose of acetaminophen. Biochem Pharmacol (1990) 0.98
Acute acetone intoxication in a pediatric patient. Pediatr Emerg Care (1988) 0.97
Building a cooperative institutional model of IAIMS at the Yale-New Haven Medical Center. Proc Annu Symp Comput Appl Med Care (1994) 0.97
Mechanism of paracetamol toxicity. Lancet (1990) 0.97
Ibuprofen pharmacokinetics in preterm infants with patent ductus arteriosus. Clin Pharmacol Ther (2001) 0.97
N-Hydroxyacetaminophen: a microsomal metabolite of N-hydroxyphenacetin but apparently not of acetaminophen. Life Sci (1979) 0.96
Pharmacokinetics and metabolism of oral midazolam in preterm infants. Br J Clin Pharmacol (2002) 0.96
Oxidant stress in rat liver after lipopolysaccharide administration: effect of inducible nitric-oxide synthase inhibition. J Pharmacol Exp Ther (2000) 0.96
Montelukast dose selection in children ages 2 to 5 years: comparison of population pharmacokinetics between children and adults. J Clin Pharmacol (2001) 0.96
Modulation of the QT interval: effects of graded exercise and reflex cardiovascular stimulation. J Appl Physiol (1985) (1993) 0.95
Single-dose pharmacokinetics of imipenem in children. J Pediatr (1984) 0.95
The formation of arylating and alkylating metabolites of phenacetin in hamsters and hamster liver microsomes. Mol Pharmacol (1981) 0.94
Breakthrough sepsis in macrolide-resistant pneumococcal infection. Pediatr Infect Dis J (1996) 0.94
Acetaminophen intoxication during treatment: what you don't know can hurt you. Clin Pediatr (Phila) (2000) 0.94
Covalent binding of acetaminophen to N-10-formyltetrahydrofolate dehydrogenase in mice. J Pharmacol Exp Ther (1997) 0.93
Impact of a waiting room videotape message on parent attitudes toward pediatric antibiotic use. Pediatrics (2001) 0.93
Investigation of terbinafine as a CYP2D6 inhibitor in vivo. Clin Pharmacol Ther (1999) 0.93
Deferoxamine delays the development of the hepatotoxicity of acetaminophen in mice. Toxicol Lett (1999) 0.93
The cloning expression and tissue distribution of human PP2Cbeta. FEBS Lett (1998) 0.93
Nifedipine poisoning in a child. Pediatrics (1990) 0.92
The single-dose pharmacokinetics of midazolam and its primary metabolite in pediatric patients after oral and intravenous administration. J Clin Pharmacol (2001) 0.92
Argatroban therapy in pediatric patients requiring nonheparin anticoagulation: an open-label, safety, efficacy, and pharmacokinetic study. Pediatr Blood Cancer (2010) 0.92
The pharmacokinetics of continuous infusion pralidoxime in children with organophosphate poisoning. J Toxicol Clin Toxicol (1998) 0.91
Evaluation of occult acetaminophen hepatotoxicity in hospitalized children receiving acetaminophen. Pediatric Pharmacology Research Unit Network. Clin Pediatr (Phila) (2001) 0.91